Olema Pharmaceuticals, Inc (OLMA) insider trading
Every open-market stock purchase and sale by Olema Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Cyrus Harmon (Insider) sold $291K in the last 90 days.
- Last insider buy: Bain Capital Life Sciences Investors LLC (Insider), $1.7M, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $24.7M (10 sales). Last close $10.73 on Sep 3, 2026.
Recent OLMA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Jason O'Byrne (CFO) | Bought (not open market) | — |
| Jul 24, 2026 | Cyrus Harmon (Insider) | Sold | $146K |
| Jul 23, 2026 | Cyrus Harmon (Insider) | Sold | $145K |
| Jun 18, 2026 | Cyrus Harmon (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Gorjan Hrustanovic (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Andrew Rappaport (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Cynthia M Butitta (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | J. Scott Garland (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Yi Larson (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Sandra Horning (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | G. Walmsley Graham (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Ian T Clark (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bvf Partners L P/il (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Prakash Raman (Insider) | Bought (not open market) | — |
| Apr 28, 2026 | Prakash Raman (Insider) | Bought (not open market) | — |
| Apr 28, 2026 | Prakash Raman (Insider) | Bought (not open market) | — |
| Mar 4, 2026 | Shawnte Mitchell (C-suite exec) | Sold | $601K |
| Mar 4, 2026 | Shawnte Mitchell (C-suite exec) | Sold | $5.8K |
| Mar 4, 2026 | Shawnte Mitchell (C-suite exec) | Bought (not open market) | — |
| Mar 3, 2026 | Shawnte Mitchell (C-suite exec) | Sold | $345K |
| Mar 3, 2026 | Shawnte Mitchell (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Sasha Lu Austin (VP) | Bought (not open market) | — |
| Feb 2, 2026 | Naseem Zojwalla (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Naseem Zojwalla (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Sasha Lu Austin (VP) | Bought (not open market) | — |
Who's trading OLMA
- Jason O'Byrne, CFO: other filings, last Sep 1, 2026
- Cyrus Harmon, Insider: sold $744K (5 sales), last Jul 24, 2026
- Prakash Raman, Insider: other filings, last Jun 18, 2026
- Cynthia M Butitta, Insider: other filings, last Jun 18, 2026
- Ian T Clark, Insider: sold $7.9M (3 sales), last Jun 18, 2026
- J. Scott Garland, Insider: other filings, last Jun 18, 2026
- G. Walmsley Graham, Director: other filings, last Jun 18, 2026
- Sandra Horning, Insider: other filings, last Jun 18, 2026
- Gorjan Hrustanovic, Insider: other filings, last Jun 18, 2026
- Andrew Rappaport, Insider: other filings, last Jun 18, 2026
- Yi Larson, Insider: other filings, last Jun 18, 2026
- Bvf Partners L P/il, Director: other filings, last Jun 18, 2026
- Shawnte Mitchell, C-suite exec: sold $952K (3 sales), last Mar 4, 2026
- Naseem Zojwalla, C-suite exec: sold $7.5M (4 sales), last Feb 2, 2026
- Sean Bohen, CEO: other filings, last Feb 2, 2026
Get free alerts when an insider at Olema Pharmaceuticals, Inc files a new trade →